Subscribe to Antivirus: a weekly newsletter on COVID-19 research

Straight to your inbox

By Mary Beth Griggs

Antivirus Newsletter

Antivirus Newsletter

What we're learning about the coronavirus, notable news from the vaccine and treatment fronts, and stories that remind us that there's more to the case counts than just numbers. Subscribe to the newsletter here.

US COVID-19 data has never been good enough

By Nicole Wetsman August 20

The unsettling uncertainty of a breakthrough case

By Nicole Wetsman August 13

Vaccine carrots only got us so far — now, it’s time for sticks

By Nicole Wetsman July 30

Communication around masks is still terrible

By Nicole Wetsman July 23

The stakes for fighting misinformation are life and death

By Nicole Wetsman

The Olympics are still stuck in 2020

By Nicole Wetsman July 9

Rimac takes over Bugatti from VW in powerhouse electric supercar deal

By Andrew J. Hawkins July 5

40 comments / new

Full approval could make the difference for the US COVID-19 vaccine campaign

By Nicole Wetsman July 2

Who needs COVID-19 boosters?

By Nicole Wetsman June 25

The slow transitions of a lingering pandemic

COVID-19 is ebbing in some parts of the world

By Mary Beth Griggs June 19

Pharma is winning the big business popularity contest

By Nicole Wetsman June 12

Memorials to honor COVID-19 dead begin to take shape

By Mary Beth Griggs June 5

12 comments / new

The future of COVID-19 immunity looks good

By Nicole Wetsman May 29

Time, money, and the new vaccination push

By Mary Beth Griggs May 22

4 comments / new

Vaccine drives in the US are getting younger

By Mary Beth Griggs May 15

4 comments / new

We may never know the exact toll of the pandemic

By Mary Beth Griggs May 8

22 comments / new

New vaccine perks: halftime shots and savings bonds

By Mary Beth Griggs May 1

The first problem was vaccine supply. Now, it’s demand.

By Nicole Wetsman

For many, COVID-19 vaccines come with a side of side effects

Most reactions are mild — here’s what you need to know

By Mary Beth Griggs April 13

83 comments / new

We’re on the knife’s edge of the pandemic

Antivirus: a weekly digest of COVID-19 research and development

By Mary Beth Griggs April 3

48 comments / new

Vaccines are changing how we interpret COVID-19 numbers

By Nicole Wetsman March 27

Welcome to the age of vaccine diplomacy

By Mary Beth Griggs March 20

8 comments / new

Some research has gotten a huge boost during the pandemic

By Mary Beth Griggs March 13

1 comment / new

COVID-19 vaccine supplies are on the rise in the US

By Mary Beth Griggs March 6

7 comments / new

Vaccine centers embrace stickers and selfie stations

By Mary Beth Griggs February 27

5 comments / new

Stretched vaccine timelines re-enter the spotlight

By Mary Beth Griggs February 20

7 comments / new

Vaccine rollout won’t be equitable unless health care reckons with racism

By Justine Calma February 13

Why the FDA is taking 22 days to look over J&J’s data

By Mary Beth Griggs February 6

18 comments / new

A good COVID-19 vaccine is good enough

By Mary Beth Griggs January 30

27 comments / new

A year into coronavirus, we’re still counting the dead

By Mary Beth Griggs January 23

5 comments / new

CES showed off the COVID-19 mask gimmick arms race

By Nicole Wetsman

It’s 2021, and the pandemic is still here

No one wants 2021 to be 2020: The Sequel

By Mary Beth Griggs January 9

11 comments / new

A COVID-19 vaccine gets a little bit extra

By Mary Beth Griggs December 19, 2020

1 comment / new

We did the impossible thing, but not the hard thing

By Nicole Wetsman and Mary Beth Griggs December 12, 2020

27 comments / new

Preparation for a big COVID-19 vaccine rollout is underway

By Mary Beth Griggs December 5, 2020

Giving thanks during a pandemic

By Mary Beth Griggs November 21, 2020

The COVID-19 pandemic hits new highs and new lows

By Mary Beth Griggs November 14, 2020

A COVID tracing app misses the mark

By Mary Beth Griggs November 7, 2020

A Swiss cheese approach to pandemic safety

By Mary Beth Griggs October 31, 2020